🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Bladder and Bowel Dysfunction

Safety and Performance of UCon Patch Electrode NCT06754189NA3 sites📍 Aarhus📍 Herlev📍 Odense InnoCon Medical · Tests: Time Limited stimulation, Sham stimulation Prehabilitation in High-risk Oncologic Surgery NCT07638410NA1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Multidisciplinary Prehabilitation Program Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site📍 Austin Natera, Inc. Evaluation for NCI Surgery Branch Clinical Research Protocols NCT00001823n/a1 site📍 Bethesda National Cancer Institute (NCI) EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites📍 Anderlecht📍 Ghent📍 Wilrijk European Organisation for Research and Treatment of Cancer … · Tests: Stereotactic body radiotherapy, Palliative RT A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 NCT07186842Phase 1, Phase 218 sites📍 Denver📍 Orlando📍 Detroit BioNTech SE · Tests: BNT329, CA19-9-targeting monoclonal antibody cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881n/a17 sites📍 Duarte📍 Miami📍 Gainesville Adela, Inc Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Distance-Based Exercise to Preserve Function and Prevent Disability NCT07059884NA23 sites📍 Dublin📍 Fremont📍 Fresno Alliance for Clinical Trials in Oncology · Tests: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Exercise Intervention, Accelerometry SCS Therapy for Patients With Bladder and Bowel Dysfunction After SCI NCT07511244NA1 site📍 Beijing Beijing Tsinghua Chang Gung Hospital · Tests: Spinal Cord Stimulation and Evaluation Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival NCT06896162NA1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Expert Review, Blood or tissue samples collection., The Precision Oncology Navigation A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites📍 Los Angeles📍 Grand Rapids📍 Lake Success MacroGenics · Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion, Pembrollizumab, vobramitamab tavatecan Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial NCT07227077NA1 site📍 Milwaukee Medical College of Wisconsin · Tests: Physical Activity Promotion Intervention Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors NCT07030257Phase 1, Phase 213 sites📍 Denver📍 Orlando📍 Grand Rapids Tasca Therapeutics · Tests: CP-383 Aquarius Pilot Study to Evaluate the New Axonics Trial System NCT07335484NA5 sites📍 Birmingham📍 Macon📍 West Columbia Axonics, Inc. · Tests: Axonics External Trial System (ETS) Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors NCT03740256Phase 11 site📍 Houston Baylor College of Medicine · Tests: CAdVEC Pelvic Health Electrically Evoked Recording (PEER) 2 Study NCT05200923NA7 sites📍 Indianapolis📍 New Orleans📍 New Orleans MedtronicNeuro · Tests: Sacral Neuromodulation A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 The Vanguard Study: Testing a New Way to Screen for Cancer NCT06995898NA45 sites📍 Pleasanton📍 Cheyenne Wells📍 Denver National Cancer Institute (NCI) · Tests: Biospecimen Collection, Device Usage, Electronic Health Record Review, Multi-Cancer Detection Test, Multi-Cancer Detect… Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) NCT06116019n/a1 site📍 Berlin Charite University, Berlin, Germany · Tests: Online adaptive radiation therapy A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas NCT07217171Phase 116 sites📍 Duarte📍 Los Angeles📍 San Francisco EvolveImmune United, Inc · Tests: EVOLVE104, EVOLVE104 Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) NCT07327489n/a8 sites📍 Fort Smith📍 Frederick📍 Springfield Elephas · Tests: Biopsy SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites📍 Sacramento📍 Celebration📍 Miami Marengo Therapeutics, Inc. · Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) NCT04585750Phase 1, Phase 276 sites📍 Irvine📍 La Jolla📍 Los Angeles PMV Pharmaceuticals, Inc · Tests: rezatapopt, pembrolizumab Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury NCT06515223NA1 site📍 Stanmore University College, London · Tests: Epidural Spinal Cord Stimulation DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations NCT05786716Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Trastuzumab, Pertuzumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy